Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Adler

Showing results (51-60 of 108) with videos related to

Pageof 11
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2009
Effectiveness of donepezil, rivastigmine, and (+/-)huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: comparison with galantamineYasco Aracava, Edna F R Pereira, Miriam Akkerman, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 6, 2008
Acute toxicity of organophosphorus compounds in guinea pigs is sex- and age-dependent and cannot be solely accounted for by acetylcholinesterase inhibitionWilliam P Fawcett, Yasco Aracava, Michael Adler, et al.
Analytical Chemistry|January 7, 2009
User configurable microfluidic device for multiplexed immunoassays based on DNA-directed assemblyHendrik Schroeder, Michael Adler, Katrin Gerigk, et al.
Digestive Diseases and Sciences|September 13, 2015
Predicting a Response to Antibiotics in Patients with the Irritable Bowel SyndromeRafid Kasir, Salam Zakko, Philip Zakko, et al.
Journal of Medicinal Chemistry|December 15, 2016
Newly Designed Quinolinol Inhibitors Mitigate the Effects of Botulinum Neurotoxin A in Enzymatic, Cell-Based, and ex Vivo AssaysPaul T Bremer, Michael Adler, Cecilia H Phung, et al.
World Journal of Gastroenterology|April 13, 2011
Intrahepatic natural killer T cell populations are increased in human hepatic steatosisMichael Adler, Sarah Taylor, Kamalu Okebugwu, et al.
European Journal of Clinical Pharmacology|May 15, 2010
Pharmacokinetics of natural mistletoe lectins after subcutaneous injectionRoman Huber, Jürgen Eisenbraun, Barbara Miletzki, et al.
Toxins|November 10, 2011
The zinc-dependent protease activity of the botulinum neurotoxinsFrank J Lebeda, Regina Z Cer, Uma Mudunuri, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 29, 2005
Adaptation and performance of an immuno-PCR assay for the quantification of Aviscumine in patient plasma samplesMichael Adler, Martin Langer, Klaus Witthohn, et al.
Microorganisms|May 28, 2022
Preclinical Evidence for the Role of Botulinum Neurotoxin A (BoNT/A) in the Treatment of Peripheral Nerve InjuryMichael Adler, Sabine Pellett, Shashi K Sharma, et al.
Pageof 11

Showing results (51-60 of 108) with videos related to

Sort By:
Pageof 11
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2009
Effectiveness of donepezil, rivastigmine, and (+/-)huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: comparison with galantamineYasco Aracava, Edna F R Pereira, Miriam Akkerman, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 6, 2008
Acute toxicity of organophosphorus compounds in guinea pigs is sex- and age-dependent and cannot be solely accounted for by acetylcholinesterase inhibitionWilliam P Fawcett, Yasco Aracava, Michael Adler, et al.
Analytical Chemistry|January 7, 2009
User configurable microfluidic device for multiplexed immunoassays based on DNA-directed assemblyHendrik Schroeder, Michael Adler, Katrin Gerigk, et al.
Digestive Diseases and Sciences|September 13, 2015
Predicting a Response to Antibiotics in Patients with the Irritable Bowel SyndromeRafid Kasir, Salam Zakko, Philip Zakko, et al.
Journal of Medicinal Chemistry|December 15, 2016
Newly Designed Quinolinol Inhibitors Mitigate the Effects of Botulinum Neurotoxin A in Enzymatic, Cell-Based, and ex Vivo AssaysPaul T Bremer, Michael Adler, Cecilia H Phung, et al.
World Journal of Gastroenterology|April 13, 2011
Intrahepatic natural killer T cell populations are increased in human hepatic steatosisMichael Adler, Sarah Taylor, Kamalu Okebugwu, et al.
European Journal of Clinical Pharmacology|May 15, 2010
Pharmacokinetics of natural mistletoe lectins after subcutaneous injectionRoman Huber, Jürgen Eisenbraun, Barbara Miletzki, et al.
Toxins|November 10, 2011
The zinc-dependent protease activity of the botulinum neurotoxinsFrank J Lebeda, Regina Z Cer, Uma Mudunuri, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 29, 2005
Adaptation and performance of an immuno-PCR assay for the quantification of Aviscumine in patient plasma samplesMichael Adler, Martin Langer, Klaus Witthohn, et al.
Microorganisms|May 28, 2022
Preclinical Evidence for the Role of Botulinum Neurotoxin A (BoNT/A) in the Treatment of Peripheral Nerve InjuryMichael Adler, Sabine Pellett, Shashi K Sharma, et al.
Pageof 11